Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Australian Commission on Safety and Quality in Healthcare (ACSQHC) (2011) National Safety and Quality Health Service Standards. ACSQHC, Canberra, pp 34–39
Australian Institute of Health and Welfare (AIHW) (2009) Australian hospital statistics 2007–8. AIHW, Canberra
Cheek D, Basshore L, Brazeau D (2015) Pharmacogenomic and implications for nursing practice. J Nurs Scholarsh 47(6):496–504
Commonwealth Department of Health and Aging (2002) The quality use of medicines. Commonwealth Department of Health and Aging, Canberra
Cramer J, Roy A, Burrell A, Fairchild C, Fuldeore M, Ollendorf D, Wong P, International Society for Pharmacoeconomics for Outcomes Research Working Group (2007) Medication compliance and persistence: terminology and definitions. Value Health 11(1):4447
Cryer P, Davis S, Shamoon H (2003) Hypoglycaemia in diabetes. Diabetes Care 26(6):1902–1912. www.health.gov.au/internet/main/publishing.nsf/content/nmp-quality.htm
Davis T, Federman A, Bass P, Jackson R et al (2009) Improving patient understanding of prescription drug label instructions. J Gen Intern Med 24:57–62
Di Matteo M, Giordani P, Lepper H, Croghan T (2002) Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 40(9):794–811
Diabetes Australia. (DA) (2011) A new language for diabetes: improving communication with and about people with diabetes. DA, Canberra
Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the progression of long term complications of insulin dependent diabetes. N Engl J Med 329:977–986
Dickinson J, Guzman S, Melinda D et al (2017) The use of language in diabetes care and education. Diabetes Care. care.diabetesjournals.org/content/early/2017/09/26/dci17-0041
Dooley M, Wiseman M, McRae A et al (2011) Reducing potentially fatal errors associated with high doses of insulin: a successful multifaceted multidisciplinary prevention strategy. Br Med J. https://doi.org/10.1136/bmjqs.2010.049668
Dunning T (2003) Complementary therapies and diabetes. Complement Ther Nurs Midwifery 9:74–80
Dunning T, Manias E (2005) Medication knowledge and self-management by people with Type 2 diabetes. Aust J Adv Nurs 11:172–181
Dunning T, Sinclair S (2014) Glucose lowering medicines and older people with diabetes: the importance of comprehensive assessments and pharmacovigilance. J Nurs Care 3(3):1–9
Dunning T, Savage S, Duggan N. (2013) The McKellar guidelines for managing older people with diabetes.in residential and other care settings. http://www.adma.org.au/clearinghouse/doc_details/133-the-mckellar-guidelines-for-managing-older-people-with-diabetes-in-residential-and-other-care-settings_9dec2013.html
Dunning T, Speight J, Bennett C (2017) Language, the ‘diabetes restricted code/dialect,’ and what it means for people with diabetes and clinicians. Diabetes Educ 47(1):18–26
Egede L, Xiaobou Y, Zheng D, Silverstein M (2002) The prevalence and pattern of complementary and alternative medicine use in individuals with diabetes. Diabetes Care 25:324–329
Eldred B, Dean A, McGuire T, Nash A (2006) Vaccine components and constituents: responding to consumer concerns. Med J Aust 2184(4):170–175
Evrard A, Mbatchi L (2012) Genetic polymorphisms of drug metabolizing enzymes and transporters. The long way from bench to bedside. Curr Top Mol Chem 12(15):1720–1729
Family Caregiver Alliance (2010) http://www.caregiver.org/caregiver/jsp/content_node.jspp?nodeid=1822
Fowler D. Rayman G. (2010) Safe and effective use of insulin in hospitalised patients. National Health Service London. http://www.diabetes.nhs.uk/document.php?o=1040. Accessed Jan 2011
Glisky E, Rubin S, Davidson S (2001) Source memory in older adults: an encoding or retrieving problem. J Exp Psychol 27(5):1131–1146
Green J, Hawley J, Rask K (2007) Is the number of prescribing physicians an independent risk factor for adverse drug events in an elderly outpatient population? Am J Geriatr Pharmacother 5(1):31–39
Hilmer S, Gnijidic D, Le Couteur D (2013) Thinking through the medication list. Aust Fam Physician 12:924–928
Institute of Safe Medicine Practice (ISMP) 2008. www.ismp.org . Accessed Jan 2011.
International Diabetes Federation (IDF) (2013) Language philosophy. www.idf.org
Jenkins R, Vaida A. (2007) Simple strategies to avoid medication errors. AAFP http://www.aafp.org/fpm/2007/0200p41.html . Accessed Dec 2009.
Johnson J (2011) Drug target pharmacogenetics. Am J Pharmacogenomics 4:315–322
Li F, Harmer P, Fisher J et al (2005) Tai chi and fall reduction in older adults: a randomized controlled trial. J Gerontol: Med Sci 60A(2):187–194
Lim L, McStea M, Chung W et al (2017) Prevalence, risk factors and health outcomes associated with polypharmacy among urban community-dwelling older adults in multi-ethnic Malaysia. PLoS One. https://doi.org/10.1371/journal.pone.0173466
Mallikarjun V, Swift J (2016) Therapeutic manipulation of ageing: repurposing old dogs and discovering new tricks. EBioMedicnine. https://doi.org/10.1016/j.ebiom.2016.11.o2o
Manya K, Champion B, Dunning T (2012) The use of complementary and alternative medicine among people living with diabetes in Sydney. BMC Complement Altern Med. https://doi.org/10.1166/1472-6882-12-2
Mosby’s Medical Dictionary (2009) 8th ed. Elservier.
National Heart Foundation of Australia (NHFA) (2011) Improving Adherence in cardiovascular care. NHFA
Newman B. (2010) Safety first. Nursing Rev 26
O’Mahony D, O’Sullivan D, Byrne S et al (2015) STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing 44(2):213–218. https://doi.org/10.1093/ageing/afu145
Palliative Care—palliAGED (2017). https://www.palliaged.com.au/tabid/4338/Default.aspx
Pearson E (2016) Personalized medicine in diabetes: the role of ‘omics’ and biomarkers. Diabet Med 13(6):712–717
Rogers E, Yost K, Rosedahl J et al (2017) Validating the patient experience with treatment self-management (PETS), a patient-reported measure of treatment burden, in people with diabetes. Patient Rel Outcome Meas 8:143–156
Rommers M, Teepe-Twiss I, Guchelaar H-J (2007) Preventing adverse drug events in hospital practice: an overview. Pharmacepidemiol Drug Saf 16:1129–1135
Roughead E, Lexchin J (2006) Adverse drug events: counting s not enough, action is needed. Med J Aust 184(7):315–316
Sav A, Whitty J, McMillan S et al (2016) Treatment burden and chronic illness: who is most at risk? Patient 9(6):559–569
Savage S, Dunning T, Duggan N, Martin P (2012) The experiences and care preferences of people with diabetes at the end of life. J Hospice Palliative Care Nurs. https://doi.org/10.1097/NJH.0601e3184bdb39
Shrank W, Libeman J, Fischer M, Kiabuk E, Girdish C, Curtrona S, Brennan T, Chudhry N (2011) Are caregivers adherent to their own medications? J Am Pharm Assoc 51(4):492–498
Simpson S, Eurich D, Sadjeedp S, Ross I, Varney J, Johnson J (2006) A meta-analysis of the association between adherence to drug therapy and mortality. Br Med J 333:15–18
Sissung T, Goey A, Ley A et al (2014) Pharmacogenetics of membrane transporters: a review of current approaches. Methods Mol Biol 1175:91–120
Stowasser D, Allison Y, O’Leary Karen M (2004) Understanding the medicine management pathway. J Pharmacol Pract Res 34:293–296
The Pharmacy Guild of Australia (2010) Medindex: a medicine compliance indicator. The Pharmacy Guild of Australia, Canberra. http://www.medsindex.com.au
United Kingdom National Prescribing Centre (2004) Task Force on Medicines Partnership. Drugs of porcine origin and their clinical alternatives. An introductory guide; March 2004. Available from: http://www.mcb.org.uk/uploads/PBEnglish.pdf
United Kingdom Prospective Study (UKPDS 33, 34) (1998) Intensive blood glucose control. Lancet 352(837–853):854–865
Williams A, Manias E, Walker R (2008) Interventions to improve medication adherence in people with multiple chronic conditions: a systematic review. J Adv Nurs 63(2):132–143
Wolfstadt J, Gurwitz J, Field T, Lee M, Kalkar S, Wu W, Rochon P (2008) The effect of computerized physician order entry and clinical decision support on the rates of adverse drug events: a systematic review. J Gen Intern Med 23(4):451–458
World health Organisation (WHO) (2003) Adherence to long-term therapies: evidence for action. WHO, Geneva
Yasuda S, Zhang L, Huang S-M (2016) The role of ethnicity in variability in response to drugs: focus on clinical pharmacology. Stud Nat Pharmacol. http://www.tda.gov.downlods/Drugs/ScienceResearch/.../UCM0865502.pdf
Young-Hyman D, de Groot M, Hill-Briggs E et al (2016) Psychosocial care for people with diabetes: a position statement of the American Diabetes Association. Diabetes Care 29(12):2126–2140
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Dunning, T. (2018). Medicines and Older People with Diabetes: Beliefs, Benefits and Risks. In: Dunning, T. (eds) The Art and Science of Personalising Care with Older People with Diabetes. Springer, Cham. https://doi.org/10.1007/978-3-319-74360-8_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-74360-8_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-74359-2
Online ISBN: 978-3-319-74360-8
eBook Packages: MedicineMedicine (R0)